As of January 22, 2025, Cosmo Pharmaceuticals (C43.F) has a market cap of $1.17 billion USD. According to our data, Cosmo Pharmaceuticals is ranked No.4973 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.17 B |
3.36%
|
Dec 30, 2024 | $1.13 B |
27.39%
|
Dec 29, 2023 | $0.89 B |
-10.21%
|
Dec 30, 2022 | $0.99 B |
1.94%
|
Dec 30, 2021 | $0.97 B |
-19.48%
|
Dec 30, 2020 | $1.20 B |
10.79%
|
Dec 30, 2019 | $1.08 B |
-11.13%
|
Dec 28, 2018 | $1.22 B |
-36.96%
|
Dec 29, 2017 | $1.93 B |
-20.44%
|
Dec 30, 2016 | $2.43 B |
7.94%
|
Dec 30, 2015 | $2.25 B |
947.13%
|
Dec 30, 2014 | $0.22 B |
0.00%
|
Dec 30, 2013 | $0.22 B |
0.00%
|
Dec 28, 2012 | $0.22 B |
0.00%
|
Dec 30, 2011 | $0.22 B |
0.00%
|
Dec 30, 2010 | $0.22 B |
22.41%
|
Dec 30, 2009 | $0.18 B |
11.75%
|
Dec 30, 2008 | $0.16 B |
-19.10%
|
Dec 28, 2007 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Market Cap | = | C43.F Stock Price | * | C43.F Shares Outstanding |
= | $71.83 | * | 16.05 M | |
= | $1.17 B |